Partnering for the Future of Human Health®
We are currently seeking partners and investors for:
- Amylon™ LLC, which is developing a novel alpha-secretase modulator, APH-1104, for mild to moderate Alzheimer’s disease and other CNS disorders such as Down’s syndrome and glaucoma.
- Zindol® LLC, which is developing Zindol® for chemotherapy-induced nausea and vomiting (CINV), and other nausea/vomiting-induced conditions caused by pregnancy, motion sickness, and drugs.
If you are interested in receiving further information, please contact us. We are also seeking partners and investors to further the development and utilization of our enabling technology platforms and enhanced therapeutic products pipeline. We are interested in working with individuals and companies dedicated to improving quality of life, maintaining health and treating unmet medical needs.
Our current and past partners include:
- Multinational as well as emerging pharmaceutical and biotechnology companies
- National and international research institutions
We support targeted relationships that are mutually beneficial and which yield results that improve patients’ lives. We continue to look for partnerships within the industry that promote this goal.
We seek committed investors and smart money to accelerate the development of our enhanced therapeutic products, promote the commercialization of our enabling technology platforms and share in the fruits of our success.
We invite you to explore our website to gain an understanding of our company and how we may join with you to develop new medicines and new technologies and enhance existing products and technologies to improve the lives of patients everywhere.